Mangoceuticals Inc. (MGRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.58
0.00 (0.00%)
At close: Jan 15, 2025, 10:56 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | 731.49K | 8.94K | n/a |
Cost of Revenue | 299.99K | 4.09K | n/a |
Gross Profit | 431.50K | 4.85K | n/a |
Operating Income | -9.22M | -1.99M | -17.52K |
Interest Income | n/a | n/a | n/a |
Pretax Income | -9.21M | -2.00M | -17.70K |
Net Income | -9.21M | -2.00M | -17.70K |
Selling & General & Admin | 8.55M | 2.00M | 17.52K |
Research & Development | n/a | n/a | n/a |
Other Expenses | 1.10M | n/a | n/a |
Operating Expenses | 9.65M | 2.00M | 17.52K |
Interest Expense | n/a | 6.47K | 181.00 |
Selling & Marketing Expenses | 2.10M | 352.86K | -52.56K |
Cost & Expenses | 9.95M | 2.00M | 17.52K |
Income Tax | n/a | -224.62K | -70.08K |
Shares Outstanding (Basic) | 1.43M | 17.32M | 17.32M |
Shares Outstanding (Diluted) | 1.43M | 17.32M | 17.32M |
EPS (Basic) | -6.45 | -0.12 | -0.00 |
EPS (Diluted) | -6.45 | -0.12 | -0.00 |
EBITDA | -9.19M | -1.99M | 52.56K |
Depreciation & Amortization | 24.89K | 3.86K | 70.08K |